Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad,

June 20, 2017 updated by: Osvaldo A. Reyes T., Saint Thomas Hospital, Panama

Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad. A Randomized, Controlled Trial.

Obstetrical blood loss is an important reason of maternal morbidity and mortality. Because of the increase in the rate of cesarean section, any procedure that could help reduce blood loss during cesarean section should be investigated. The purpose of this study was to compare 2 methods of blunt expansion of the uterine incision at the time of cesarean delivery: transversal vs. cephalad-caudad.

Study Overview

Study Type

Interventional

Enrollment (Actual)

839

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Panama, Panama
        • Saint Thomas Maternity Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Singleton pregnancies
  • Gestational age: 34 weeks or more
  • Delivery by cesarean section
  • Presurgical hemoglobin > 10.5 g/dL

Exclusion Criteria:

  • Two or more previous cesarean sections
  • History of uterine rupture in a previous pregnancy
  • History of myomectomy
  • History of abdominal trauma with an uterine lesion
  • Blood dyscrasia
  • Multiple pregnancy
  • Placenta previa
  • Abruptio placenta
  • Stillbirth
  • Sharp uterine expansion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cephalad-caudad
Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.
Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.
Experimental: Transversal expansion
Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.
Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood loss (hemoglobin level)
Time Frame: 72 hours
Difference in hemoglobin level between 24 hours pre-surgery and the hemoglobin level before leaving the hospital.
72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical complications
Time Frame: 72 hours
Number of cases of surgical complications (hematomas, unintended extension of the uterine incision, need for transfusion) between the two techniques.
72 hours
Unintented extension of uterine incision
Time Frame: 72 hours
Number of cases of unintended extension of the uterine incision during surgery between the two techniques.
72 hours
Hematoma formation
Time Frame: 72 hours
Number of cases of hematoma formation during or after between the two techniques.
72 hours
Need for transfusion
Time Frame: 72 hours
Number of cases that required a blood transfusion between the two techniques.
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Osvaldo Reyes, MD, Saint Thomas Maternity Hospital
  • Principal Investigator: Alberto Morales, MD, Saint Thomas Maternity Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

June 30, 2013

First Submitted That Met QC Criteria

June 30, 2013

First Posted (Estimate)

July 4, 2013

Study Record Updates

Last Update Posted (Actual)

June 22, 2017

Last Update Submitted That Met QC Criteria

June 20, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MHST2012-08

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blunt Expansion of the Uterine Incision

Clinical Trials on Cephalad-caudad expansion

Subscribe